Abstract:Highlights • Three novel cathelicidin antimicrobial peptides were obtained by protein databases mining. • TS-CATH from Thamnophis sirtalis shows broad-spectrum antibacterial activity with negligible cytotoxicity in vitro . • TS-CATH protected mice from bacteremia and promoted infected wound closure in vivo . • TS-CATH destabilizes the bacterial respiratory chain, inducing ROS, which assists in antibacterial activity. Antimicrobial peptides are promising therapeutic agents for treating drug-resistant bacterial disease due to their broad-spectrum antimicrobial activity and decreased susceptibility to evolutionary resistance. In this study, three novel cathelicidin antimicrobial peptides were identified from Thamnophis sirtalis , Balaenoptera musculus , and Lipotes vexillifer by protein database mining and sequence alignment and were subsequently named TS-CATH, BM-CATH, and LV-CATH, respectively. All three peptides exhibited satisfactory antibacterial activity and broad antibacterial spectra against clinically isolated E. coli , P. aeruginosa , K. pneumoniae , and A. baumannii in vitro . Among them, TS-CATH displayed the best antimicrobial/bactericidal activity, with a rapid elimination efficiency against the tested drug-resistant gram-negative bacteria within 20 minutes, and exhibited the lowest cytotoxicity toward mammalian cells. Furthermore, TS-CATH effectively enhanced the survival rate of mice with ceftazidime-resistant E. coli bacteremia and promoted wound healing in meropenem-resistant P. aeruginosa infection. These results were achieved through the eradication of bacterial growth in target organs and wounds, further inhibiting the systemic dissemination of bacteria and the inflammatory response. TS-CATH exhibited direct antimicrobial activity by damaging the inner and outer membranes, resulting in leakage of the bacterial contents at super-MICs. Moreover, TS-CATH disrupted the bacterial respiratory chain, which inhibited ATP synthesis and induced ROS formation, significantly contributing to its antibacterial efficacy at sub-MICs. Overall, TS-CATH has potential for use as an antibacterial agent. Graphical abstract Download : Download high-res image (192KB) Download : Download full-size image

The Antimicrobial Peptide Cathelicidin-Bf Could Be A Potential Therapeutic for Salmonella Typhimurium Infection

A novel cathelicidin TS-CATH derived from Thamnophis sirtalis combats drug-resistant gram-negative bacteria in vitro and in vivo

Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics

The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus

Antimicrobial Peptide JH-3 Effectively Kills Salmonella enterica Serovar Typhimurium Strain CVCC541 and Reduces Its Pathogenicity in Mice

Effects of a Novel Bacillus Subtilis GXYX Crude Lipopeptide Against Salmonella Enterica Serovar Typhimurium Infection in Mice

Insight into the inhibitory activity and mechanism of bovine cathelicidin BMAP 27 against Salmonella Typhimurium

Design of a Sea Snake Antimicrobial Peptide Derivative with Therapeutic Potential Against Drug-Resistant Bacterial Infection.

The lasso peptide produced by Bacillus licheniformis MCC 2514 demonstrates efficacy in treating in-vivo Salmonella Typhimurium infection

Evaluation of therapeutic efficacy of antimicrobial peptide JH-3 in Salmonella infection

Bioactive Triple Peptide Inhibits Inflammasome Activation to Alleviate Salmonella-induced Intestinal Inflammation in Mice Via Modulation of Host Defense and Bacterial Virulence

The lasso peptide produced by Bacillus licheniformis MCC 2514 demonstrates efficacy in treating in-vivoSalmonella Typhimurium infection

Designed Symmetrical Β-Hairpin Peptides for Treating Multidrug-Resistant Salmonella Typhimurium Infections.

Antibacterial Peptide BSN-37 Kills Extra- and Intra-Cellular Salmonella Enterica Serovar Typhimurium by a Nonlytic Mode of Action

Antimicrobial Peptide Cathelicidin-BF Prevents Intestinal Barrier Dysfunction in a Mouse Model of Endotoxemia.

Bacillus velezensis HBXN2020 alleviates Salmonella Typhimurium infection in mice by improving intestinal barrier integrity and reducing inflammation

Lasso peptide MccY alleviates non-typhoidal salmonellae-induced mouse gut inflammation via regulation of intestinal barrier function and gut microbiota

Tree Frog-Derived Cathelicidin Protects Mice against Bacterial Infection through Its Antimicrobial and Anti-Inflammatory Activities and Regulatory Effect on Phagocytes

The Protective Role of Chicken Cathelicidin-1 Against Streptococcus Suis Serotype 2 in Vitro and in Vivo.

Cathelicidin-BF, a Novel Antimicrobial Peptide from Bungarus fasciatus, Attenuates Disease in a Dextran Sulfate Sodium Model of Colitis